Targeted therapy to prevent progression of calcific aortic stenosis.
Rajamannan
Nalini M
NM
Otto
Catherine M
CM
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D001021:Aortic Valve / Q000473:pathology; D001024:Aortic Valve Stenosis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D002114:Calcinosis / Q000188:drug therapy*; D018450:Disease Progression; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy; D007249:Inflammation; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology; D012189:Retrospective Studies; D012598:Sclerosis
D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors